Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicplas InternationalSGX:569 Median PS Value is S$0.17 as of Aug. 03, 2026, which is 100% below its 10-year median of 0.82. The stock has 5 warning signs investors should review. Among 336 Medical Devices & Instruments companies, Vicplas International ranks better than 74.11% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Vicplas International's Median PS Value or its related term are showing as below:
SGX:569'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.45 Med: 0.82 Max: 1.46
Current: 0.45
During the past 13 years, the highest Price to Median PS Value of Vicplas International was 1.46. The lowest was 0.45. And the median was 0.82.
SGX:569's Price-to-Median-PS-Value is ranked better than 74.11% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs SGX:569: 0.45
Vicplas International (SGX:569) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Vicplas International's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.077
/
0.17
=
0.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicplas International Median PS Value Related Terms
Vicplas International Median PS Value Historical Data
* Premium members only.
The historical data trend for Vicplas International's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:569 vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Vicplas International's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicplas International Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Vicplas International's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.7025.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2026 was S$0.242.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicplas International (SGX:569) has a Median PS Value of S$0.17 as of Aug. 03, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vicplas International and its competitors. This is 79% below median its historical median of 0.82. Over the past decade, Vicplas International's Median PS Value has ranged from 0.45 to 1.46. According to the industry distribution chart, Vicplas International ranks #87 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 25.9%.
Is Vicplas International's Median PS Value too high?
Vicplas International's current Median PS Value of S$0.17 is 79% below median its 10-year median of 0.82. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 1.46. Based on the distribution chart, Vicplas International ranks #87 out of 336 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vicplas International's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vicplas International ranks #87 out of 336 companies for Median PS Value. This puts Vicplas International in the upper half of its industry. The industry median Median PS Value is 0.71. Historically, Vicplas International's own Median PS Value has ranged from 0.45 to 1.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vicplas International and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicplas International's current Median PS Value is S$0.17, which is 79% below median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicplas International stock overvalued right now?
Based on GuruFocus' analysis, Vicplas International (SGX:569) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.11, compared to a current price of S$0.08 — trading 30% below its estimated fair value. The current Median PS Value is S$0.17, which is 79% below median its 10-year median of 0.82. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Vicplas International (SGX:569), the current Median PS Value is S$0.17 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:569 has been successfully added to your 
